Description:
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Nucleotide and Nucleic Acid Metabolism |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
Black/African American
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
ISCN
|
arr 1q24.1q32.1(165741530-199272729)x1,15q11.1q11.2(20541967-22311799)x1
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.74 |
Passage Frozen |
6 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Gene |
XPC |
Chromosomal Location |
3p25 |
Allelic Variant 1 |
613208.0001; XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C |
Identified Mutation |
PRO218HIS; In cell line XP1MI, Li et al. [Nature Genet. 5: 413-417, (1993)] found, by complete sequencing of the 2,472 bp coding sequence of the XPC gene, a point mutation that converted proline at position 218 to histidine. The finding suggested that the cell line was either homozygous or hemizygous for this mutation. The XP1MI cell line was the most UV-sensitive of the five cell lines analyzed by Li et al. [Nature Genet. 5: 413-417, (1993)]. Furthermore, the patient demonstrated XP-associated neurologic abnormalities, a rarity in group C. |
Remarks |
De Sanctis-Cacchione; lupus erythematosus; see GM02634 (lymphoblastoid); XP1MI; 46,XX; low level of UV induced unscheduled DNA synthesis; XP-associated neurologic abnormalities, a rarity in group C; the donor subject carries a point mutation that converts the proline at position 218 to histidine [Pro218His (P218H)]. The cell line is either homozygous or hemizygous for this mutation. |
Bidon B1,2,3,4, Iltis I1,2,3,4, Semer M1,2,3,4, Nagy Z1,2,3,4, Larnicol A1,2,3,4, Cribier A5, Benkirane M5, Coin F6,7,8,9, Egly JM10,11,12,13, Le May N14,15,16,17., XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1 Nature Communications9: 2018 |
PubMed ID: 29973595 |
|
Wang D, Yang H, Zhou Z, Zhao M, Chen R, Reed SH, XPF plays an indispensable role in relieving silver nanoparticle induced DNA damage stress in human cells Toxicology letters288:44-54 2017 |
PubMed ID: 29462690 |
|
Tang Z, Berlin DS, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP, A dynamic database of microarray-characterized cell lines with various cytogenetic and genomic backgrounds G3 (Bethesda, Md)3:1143-9 2013 |
PubMed ID: 23665875 |
|
Ray A, Milum K, Battu A, Wani G, Wani AA, NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites DNA repair3:1143-9 2012 |
PubMed ID: 23422745 |
|
Cartault F, Nava C, Malbrunot AC, Munier P, Hebert JC, N'guyen P, Djeridi N, Pariaud P, Pariaud J, Dupuy A, Austerlitz F, Sarasin A, A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients DNA repair10:577-85 2011 |
PubMed ID: 21482201 |
|
Jeyapalan JN, Varley H, Foxon JL, Pollock RE, Jeffreys AJ, Henson JD, Reddel RR, Royle NJ, Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Hum Mol Genet14(13):1785-94 2005 |
PubMed ID: 15888482 |
|
Wang G, Chuang L, Zhang X, Colton S, Dombkowski A, Reiners J, Diakiw A, Xu XS, The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res32(7):2231-40 2004 |
PubMed ID: 15107491 |
|
Wang QE, Zhu Q, Wani MA, Wani G, Chen J, Wani AA, Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage DNA repair2:483-99 2003 |
PubMed ID: 12713809 |
|
Cleaver JE, Thompson LH, Richardson AS, States JC, A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum,
Cockayne syndrome, and trichothiodystrophy. Hum Mutat14(1):9-22 1999 |
PubMed ID: 10447254 |
|
Perelman B, Dafni N, Naiman T, Eli D, Yaakov M, Feng TL, Sinha S, Weber G, Khodaei S, Sancar A, Dotan I, Canaani D, Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus. Genomics41:397-405 1997 |
PubMed ID: 9169138 |
|
Canaani D, Naiman T, Teitz T, Berg P, Immortalization of xeroderma pigmentosum cells by simian virus 40 DNA having a defective origin of DNA replication. Somat Cell Mol Genet12:13-20 1986 |
PubMed ID: 3003928 |
|
Karentz D, Cleaver JE, Excision repair in xeroderma pigmentosum group C but not group D is clustered in a small fraction of the total genome. Mutat Res165:165-74 1986 |
PubMed ID: 3084965 |
|
Cleaver JE, DNA repair deficiencies and cellular senescence are unrelated in xeroderma pigmentosum cell lines. Mech Ageing Dev27:189-96 1984 |
PubMed ID: 6492896 |
|
Cleaver JE, Charles WC, Kong SH, Efficiency of repair of pyrimidine dimers and psoralen monoadducts in normal and xeroderma pigmentosum human cells. Photochem Photobiol40:621-9 1984 |
PubMed ID: 6514810 |
|
Robbins JH, Polinsky RJ, Moshell AN, Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum. Ann Neurol13:682-4 1983 |
PubMed ID: 6881931 |
|
Cleaver JE, Zelle B, Hashem N, El-Hefnawi MH, German J, Xeroderma pigmentosum patients from Egypt: II. Preliminary correlations of epidemiology, clinical symptoms and molecular biology. J Invest Dermatol77:96-101 1981 |
PubMed ID: 7252263 |
|
Hananian J, Cleaver JE, Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus. Clin Genet17:39-45 1980 |
PubMed ID: 7389185 |
Cumulative PDL at Freeze |
5.74 |
Passage Frozen |
6 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|